Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-15
2011-03-15
Chung, Susannah (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S277000, C544S224000, C546S304000
Reexamination Certificate
active
07906517
ABSTRACT:
The present invention relates to a compound of the general formula (1):wherein, Y is a methylene group, and the like; A is an optionally substituted heterocyclic group, and the like; B is an optionally substituted phenyl group, and the like; R1is an optionally substituted alkyl group, and the like; and R2is an optionally substituted amino group, and the like; or a pharmaceutically acceptable derivative thereof, which has an inhibitory activity against cholesteryl ester transfer protein (CETP), thereby being useful for prophylaxis and/or treatment of arteriosclerotic diseases, hyperlipemia or dyslipidemia, and the like.
REFERENCES:
patent: 5536718 (1996-07-01), Albright et al.
patent: 6685617 (2004-02-01), Blinn et al.
patent: 7332514 (2008-02-01), Maeda et al.
patent: 2002/0156281 (2002-10-01), Booth et al.
patent: 2010/0167986 (2010-07-01), Ali et al.
patent: 0 129 433 (1984-06-01), None
patent: 1 426 360 (2004-06-01), None
patent: 1 533 292 (2005-05-01), None
patent: 2003-221376 (2003-08-01), None
patent: WO-00/17164 (2000-03-01), None
patent: WO-00/17165 (2000-03-01), None
patent: WO-00/17166 (2000-03-01), None
patent: WO-03/063868 (2003-08-01), None
patent: WO-2004/020393 (2004-03-01), None
patent: WO-2005/100298 (2005-10-01), None
patent: WO-2006/056854 (2006-06-01), None
patent: WO-2006/073973 (2006-07-01), None
patent: WO-2007/041494 (2007-04-01), None
English Translation of International Preliminary Report on Patentability, PCT/JP2007/051861, Aug. 5, 2008.
International Search Report, PCT/JP2007/051861, Dec. 6, 2007.
Massa et al., “Novel Heteroaryl Replacements of Aromatic 2-Tetrafluoroethoxy Substituents in Trifluoro-3-(tertiaryamino)-2-propanols as Potent Inhibitors of Cholesteryl Ester Transfer Protein”, Biorganic & Medicinal Chemistry letters, vol. 11, pp. 1625-1628, (2001).
European Application No. 06816017.5; Office Action, Nov. 17, 2009, 6 pages.
European Application No. 6816017.5, Response filed May 27, 2010.
European Application No. 06 816 017.5, Office Action, Nov. 2, 2010, 4 pages.
U.S. Appl. No. 11/922,616, Office Action, Oct. 13, 2010, 8 pages.
Hayashi Norimitsu
Higashijima Takanori
Kubota Hitoshi
Nakamura Yoshinori
Oka Kozo
Birch & Stewart Kolasch & Birch, LLP
Chung Susannah
Mitsubishi Tanabe Pharma Corporation
LandOfFree
Trisubstituted amine compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trisubstituted amine compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trisubstituted amine compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2627856